Deliver Your News to the World

Cardiac Marker Breakthrough


Sept. 15th, 2007 ST. Louis: Lee Biosolutions, Inc has increased production of cardiac marker Myeloperoxidase from Neutrophils due to high demand.

Current research explains how a single initial measurement of plasma myeloperoxidase (mpo), which is found in white blood cells, independently predicts the early risk of cardiovascular disease. In addition,research suggests that myeloperoxidase levels can predict the risk of major adverse cardiac events such as ischemia, myocardial infarction, and congestive heart failure, as well as heart cancer, Multiple Sclerosis, and other ailments.

Doctors believe that myeloperoxidase
blood tests would first be used in emergency rooms to distinguish patients who are genuinely at risk of a cardiac emergency from the millions who have chest pain from other causes. Eventually, the test may be offered in doctorsí offices as part of a battery of blood tests capable of identifying those who have heart disease but arenít aware. Doctors will be able to diagnose an imminent heart attack sooner and act quickly to prevent it.

Lee Biosolutions manufactures enzymes and related proteins and antigens to research facilities around the world that develop tests in order to advance the healthcare industry. By providing solutions on demand, Lee Biosolutions has become the preferred producer and source for myeloperoxidase.

According to Burton Lee, President of Lee Biosolutions, Myeloperoxidase is only one of several cardiac markers which have been in high demand for some time. Lee Biosolutions supplies Native Human Myeloperoxidase, Native and recombinant Human Cardiac Troponin I,T,C, Human Creatine Kinase isoenzyme MB (CKMB) and CK MM, Lactate Dehydrogenase, Serum Amyloid P, APO A1 lipoprotein(s),human heart Myoglobin, proBNP,Alpha fetoprotein,and many other human proteins.

Lee Biosolutions is a leader in the biomaterials industry, providing the high quality products to clinical labs and researchers around the world, developing tomorrows cures. The company has provided the human proteins used in a number of high profile biomarker studies


 inflammatory marker
 cleveland clinic
 Cardiovascular disease

This news content may be integrated into any legitimate news gathering and publishing effort. Linking is permitted.

News Release Distribution and Press Release Distribution Services Provided by WebWire.